Tizanidine is a fast-acting prescription muscle relaxant used to manage spasticity from multiple sclerosis, spinal cord injury, and certain musculoskeletal conditions. As an alpha‑2 adrenergic agonist, it reduces nerve signals that cause muscle tightness, helping ease spasms, pain, and stiffness so daily activities feel more manageable. Half‑life and flexible dosing allow on‑demand relief, but drowsiness, low blood pressure, and drug interactions—especially with ciprofloxacin or fluvoxamine—require care. HealthSouth Hospital of Altamonte Springs offers a compliant path to access: complete a brief online health intake, and a licensed clinician reviews your case; when appropriate, a prescription is issued and filled by a U.S. pharmacy.
Tizanidine is a central alpha‑2 adrenergic agonist indicated for the short‑term management of spasticity. Clinicians commonly use it to reduce muscle tone, clonus, and painful spasms associated with multiple sclerosis (MS), spinal cord injury, and other neurological conditions that increase reflex excitability. By dampening excitatory nerve signaling in the spinal cord, tizanidine helps muscles relax, improving comfort, mobility, and the ability to perform daily tasks such as walking, transferring, and sleeping through the night.
In practice, tizanidine is favored when a short-acting, flexible muscle relaxant is needed. It begins working within about one to two hours and typically lasts three to six hours, making it useful for intermittent flares of spasticity or activity-related stiffness. Some clinicians also use tizanidine as an adjunct for musculoskeletal spasm or tension-related pain, though this is off‑label. It does not treat the underlying neurological disease; rather, it targets symptoms to help restore function and quality of life.
Start low and go slow. A common initial dose is 2 mg, taken up to three times a day, approximately every six to eight hours as needed for spasticity. Your prescriber may increase the dose by 2 to 4 mg per dose at intervals of a few days, based on response and tolerability. Do not exceed 36 mg in 24 hours, and do not take more than three doses in a single day, as adverse effects rise steeply at higher exposures.
Take tizanidine consistently either with food or without; switching back and forth can change how much drug your body absorbs. Tablets and capsules are not interchangeable on a milligram‑for‑milligram basis in all conditions of use, so follow your specific prescription. If you have liver or kidney problems, a lower starting dose and slower titration are needed. Never stop high or frequent dosing suddenly; discuss a taper plan with your clinician to avoid withdrawal symptoms.
Tizanidine can cause drowsiness, dizziness, and low blood pressure, especially when starting or increasing the dose. Until you know how you respond, avoid driving, operating machinery, or activities requiring full alertness. Stand up slowly to minimize lightheadedness. Dry mouth and fatigue are common. Tizanidine may elevate liver enzymes; your clinician may check liver function before treatment and periodically during therapy, particularly at higher doses or if symptoms of liver injury develop.
Use caution if you are older, have kidney impairment, or have a history of fainting or bradycardia, as you may be more sensitive to tizanidine’s effects. Alcohol and other sedatives intensify drowsiness and blood pressure lowering; avoid or limit them. During pregnancy or breastfeeding, use only if potential benefits outweigh risks, and under medical supervision. Always use the lowest effective dose for the shortest necessary duration to control symptoms.
Do not use tizanidine if you are allergic to it or any component of the formulation. Concomitant use with the potent CYP1A2 inhibitors ciprofloxacin or fluvoxamine is contraindicated. These drugs can dramatically raise tizanidine levels, triggering profound hypotension, excessive sedation, and other serious adverse reactions. If you are prescribed one of these medications, talk to your healthcare professional about alternative strategies for spasticity management.
Severe liver disease is a major concern, and tizanidine should be avoided or used only with extreme caution and close monitoring. People prone to symptomatic low blood pressure, those taking multiple antihypertensives, or those on other alpha‑2 agonists (such as clonidine) may experience additive effects and may not be good candidates. Provide your clinician with a complete medication and medical history so a safer plan can be tailored to you.
Common side effects include sleepiness, fatigue, dizziness, dry mouth, weakness, and low blood pressure. Some individuals report nausea, constipation, or back pain. These effects are often dose‑related and may lessen as your body adjusts or the dose is reduced. Taking the medication at times when sedation is less disruptive (for example, in the evening) can help, provided your prescriber agrees the timing still meets your therapeutic goals.
Serious but less common reactions include liver injury (dark urine, right‑upper abdominal pain, jaundice), severe hypotension or fainting, slow heart rate, confusion, or hallucinations. Allergic reactions—rash, swelling, wheezing—require urgent care. Abruptly stopping high or frequent doses can precipitate rebound hypertension, increased heart rate, and worsened spasticity. If you experience concerning symptoms, contact your clinician promptly; for signs of a medical emergency, call 911.
Tizanidine is metabolized primarily by CYP1A2. Strong inhibitors of this enzyme—especially ciprofloxacin and fluvoxamine—are unsafe to combine and are contraindicated. Other agents that may raise tizanidine levels include certain oral contraceptives, cimetidine, and some fluoroquinolones. Conversely, cigarette smoking induces CYP1A2 and can lower tizanidine exposure, potentially reducing effectiveness. Because many common medicines and lifestyle factors affect this pathway, seek professional guidance before starting or stopping any drug.
Additive central nervous system depression can occur with benzodiazepines, opioids, sleep medications, sedating antihistamines, gabapentinoids, and alcohol. Combining tizanidine with antihypertensives or other alpha‑2 agonists may produce excessive blood pressure lowering or bradycardia. Using multiple skeletal muscle relaxants simultaneously increases the risk of falls and sedation without improving benefit. Maintain a current medication list and share it with every prescriber and pharmacist to minimize avoidable interactions.
If you take tizanidine on a schedule and miss a dose, take it when you remember unless it is close to your next dose. If it is nearly time for the next dose, skip the missed one and resume your regular schedule. Do not double up. Consistency matters: taking tizanidine at the same times and in the same way with respect to food helps keep symptom control reliable and side effects predictable.
If you use tizanidine only as needed for peak periods of spasticity, take it at the earliest sign that your symptoms are escalating. Keep a log of the time and dose so you do not exceed three doses or 36 mg in 24 hours. If you find yourself needing frequent extra doses, contact your clinician; an adjustment of baseline therapy or alternative treatments may be appropriate.
Overdose can present with pronounced drowsiness, confusion, slurred speech, low blood pressure, slow heart rate, shallow breathing, and, in severe cases, fainting or coma. Because tizanidine depresses central nervous system activity and blood pressure, the greatest risks are falls, injury, and compromised circulation or respiration. Overdose may be more dangerous when combined with alcohol, benzodiazepines, opioids, or potent CYP1A2 inhibitors that elevate tizanidine levels.
If you suspect an overdose, call 911 or Poison Control at 1‑800‑222‑1222 immediately. Do not attempt to induce vomiting. While awaiting help, keep the person lying on their side to protect the airway if drowsy or nauseated. Treatment is supportive: healthcare professionals may use activated charcoal if ingestion was recent, monitor heart rhythm and blood pressure, and administer intravenous fluids or vasopressors as needed. Bring the medication container to the emergency department.
Store tizanidine at room temperature, ideally 68°F to 77°F (20°C to 25°C), in a dry place away from direct light. Keep tablets or capsules in the original, tightly closed container, and do not store in bathrooms where humidity is high. Always keep medicines out of reach of children and pets, and use child‑resistant caps correctly after each use to prevent accidental ingestion.
Do not share your prescription with others, even if their symptoms seem similar—tizanidine’s dosing and risks are individualized. Check expiration dates and dispose of unused or expired medication through a pharmacy take‑back program or according to local guidance; avoid flushing unless specifically instructed. If your medication changes in color, odor, or appearance, consult your pharmacist before taking another dose.
In the United States, tizanidine (brand example: Zanaflex) is a prescription medication. By law, it must be dispensed only pursuant to a valid prescription from a licensed clinician after an appropriate evaluation. HealthSouth Hospital of Altamonte Springs offers a legal, structured pathway for adults to obtain care without a prior prescription: you complete a secure online health intake, a licensed U.S. clinician reviews your information, and—if clinically appropriate—issues a legitimate prescription that is then filled by a licensed pharmacy.
This telehealth‑supported process emphasizes safety and compliance: identity and age verification, state‑based service availability, drug‑interaction screening, and clear counseling are built in. No medication is shipped without a prescription on file, and controlled substances are not provided through this service. Transparent pricing, private shipping, and responsive support make access convenient while respecting federal and state regulations. Use this option for routine, non‑urgent care; for severe or rapidly worsening symptoms, seek in‑person medical attention promptly.
Tizanidine (brand name Zanaflex) is a centrally acting muscle relaxant and alpha-2 adrenergic agonist that reduces excitatory signals to motor neurons in the spinal cord, lowering muscle tone and relieving spasticity.
It is prescribed for spasticity from multiple sclerosis, spinal cord injury, stroke, and other neurologic disorders, and sometimes off-label for short-term painful muscle spasms.
Relief often starts within about an hour, peaks at 1–2 hours, and typically lasts 3–6 hours, which is why it is commonly dosed up to three times daily as tolerated.
It comes as tablets and capsules; adults often start at 2 mg and increase gradually as needed, with a usual maximum of 36 mg per day in divided doses, guided by a clinician.
Take it the same way each time (always with food or always without) because food changes absorption, and do not switch between tablet and capsule forms without medical advice.
Drowsiness, dizziness, dry mouth, weakness, fatigue, and low blood pressure are common; some people also notice nausea or blurry vision.
Seek care for fainting, severe hypotension, slow heartbeat, confusion or hallucinations, dark urine or yellowing skin/eyes (possible liver injury), or allergic reactions like swelling or rash.
People with significant liver disease, very low blood pressure, severe kidney impairment, or those prone to falls should use caution; older adults may be more sensitive to sedation and dizziness.
Strong CYP1A2 inhibitors like ciprofloxacin and fluvoxamine can raise levels dramatically and are generally contraindicated; oral contraceptives, cimetidine, some antiarrhythmics, and certain antibiotics may also increase levels; smoking can lower levels; combining with alcohol, benzodiazepines, opioids, or other sedatives increases the risk of excessive drowsiness and hypotension.
It is best to avoid alcohol because it can intensify sedation and blood pressure drops, increasing the risk of falls, fainting, and accidents.
Yes, it can lower blood pressure and sometimes slow the heart rate; monitor for lightheadedness, especially when standing, and report persistent symptoms to your clinician.
Do not drive or use heavy machinery until you know how it affects you; many people experience drowsiness or slowed reaction times, especially after starting or increasing the dose.
Human data are limited; use only if the potential benefit outweighs risks, and discuss alternatives; it may pass into breast milk, so breastfeeding requires individualized guidance.
Your clinician may check blood pressure, liver function tests at baseline and during dose increases, and kidney function if you have renal impairment.
Take it when you remember unless it is close to the next dose; do not double up—resume your regular schedule.
Avoid abrupt discontinuation; taper gradually to reduce the risk of rebound hypertension, rapid heart rate, and return or worsening of spasticity.
Severe drowsiness, confusion, extreme weakness, slow heart rate, low blood pressure, and shallow breathing require urgent medical attention.
Yes, some people use it at bedtime for nocturnal spasms or cramps to limit daytime sedation, but dosing should be individualized by your clinician.
It is not an opioid or benzodiazepine and is not typically addictive, but physical dependence can occur; tapering is recommended to avoid withdrawal-like symptoms.
Both reduce spasticity effectively; baclofen is often first-line, while tizanidine may be preferred for intermittent or nighttime spasms due to shorter duration; tizanidine tends to cause more hypotension and dry mouth, whereas baclofen often causes more weakness.
Cyclobenzaprine is commonly used short-term for acute musculoskeletal spasms and has more anticholinergic effects (dry mouth, constipation), while tizanidine may be chosen when spasticity is neurologic or when shorter action is desired; both can cause sedation.
Methocarbamol may cause less hypotension and has a broader use in acute muscle spasm, but it can still sedate; tizanidine is often more effective for neurologic spasticity but requires careful monitoring of blood pressure and interactions.
Carisoprodol carries a higher risk of dependence, misuse, and withdrawal and is a controlled substance; tizanidine lacks that abuse profile but can cause hypotension and liver enzyme elevations, so many clinicians favor tizanidine for longer-term management under supervision.
Metaxalone is often perceived as less sedating than many muscle relaxants, but it can affect the liver; tizanidine may be more sedating and hypotensive—choice depends on symptom pattern, comorbidities, and monitoring needs.
Diazepam reduces spasticity but has higher risks of dependence, cognitive impairment, and next-day sedation; tizanidine is generally preferred for chronic use when tolerated, though both require caution with other CNS depressants.
Dantrolene works peripherally on muscle and can be effective for severe spasticity but has a higher risk of liver toxicity and requires strict monitoring; tizanidine acts centrally, has a shorter effect window, and is often used earlier or as adjunctive therapy.
Orphenadrine has anticholinergic effects (dry mouth, urinary retention, confusion), which can be problematic in older adults; tizanidine more commonly lowers blood pressure and causes sedation—selection hinges on side-effect tolerability and patient profile.
Both are effective; baclofen is frequently first-line for MS, while tizanidine can be valuable for breakthrough or nocturnal spasms and may be combined cautiously with baclofen when monotherapy is inadequate.
Baclofen has robust evidence and can be delivered intrathecally for severe cases; tizanidine is a useful oral alternative or add-on for residual spasms, with dosing tailored to minimize sedation and hypotension.
Combination therapy is sometimes used for refractory spasticity, but additive sedation and hypotension are common; start low, go slow, and monitor closely under medical supervision.
Tizanidine is hepatically metabolized and should be used cautiously—or avoided—in significant liver disease; baclofen is renally cleared and needs dose reduction in kidney impairment, so organ function guides the safer choice.
Both are alpha-2 agonists, but clonidine is primarily an antihypertensive and not a standard skeletal muscle relaxant; tizanidine is formulated and dosed for spasticity, with a different side-effect and interaction profile tailored to that use.